Insiders · Profile

Baity Glenn

EVP AND GC at ACADIA PHARMACEUTICALS. Filing since 27 Nov 2012. CIK 0001487100

Company
Date
Role
Action
Shares
Amount
Of holding
29 Jan 2018
EVP AND GC
Sold, plan not stated
36,558
$1.18M
30.4%
2 Jan 2018
EVP AND GC
Sold, plan not stated
74,321
$2.24M
51.5%
5 Oct 2017
EVP AND GC
Sold, plan not stated
37,500
$1.53M
35.0%
30 Aug 2017
EVP AND GC
Sold, plan not stated
26,507
$924.31K
28.2%
9 Aug 2017
EVP AND GC
Sold, plan not stated
14,322
$499.53K
15.6%
20 Jul 2017
EVP AND GC
Sold, plan not stated
38,097
$1.14M
34.9%
22 Jun 2017
EVP AND GC
Sold, plan not stated
1,903
$57.09K
2.3%
14 Feb 2017
EVP AND GC
Sold, plan not stated
26,365
$1.05M
28.2%
1 Feb 2017
EVP AND GC
Sold, plan not stated
31,078
$1.09M
31.7%
27 Dec 2016
EVP AND GC
Sold, plan not stated
9,800
$298.47K
12.0%
20 Dec 2016
EVP AND GC
Sold, plan not stated
10,000
$300.00K
12.3%
10 Nov 2016
EVP AND GC
Sold, plan not stated
10,200
$306.69K
13.9%
12 Jul 2016
EVP AND GC
Sold, plan not stated
11,943
$418.03K
16.0%
11 Jul 2016
EVP AND GC
Sold, plan not stated
4,057
$142.00K
6.1%
2 Mar 2016
EVP AND GC
Sold, plan not stated
7,000
$145.58K
10.0%
26 Feb 2014
VP AND GC
Sold, plan not stated
42,000
$1.27M
46.8%
22 Apr 2013
VP AND GC
Sold, plan not stated
10,000
$131.49K
20.0%
17 Apr 2013
VP AND GC
Sold, plan not stated
10,000
$122.60K
20.0%
16 Apr 2013
VP AND GC
Sold, plan not stated
20,000
$246.00K
33.3%
15 Apr 2013
VP AND GC
Sold, plan not stated
20,000
$250.00K
33.3%
12 Apr 2013
VP AND GC
Sold, plan not stated
30,000
$384.80K
42.9%
11 Apr 2013
VP AND GC
Sold, plan not stated
30,000
$360.60K
42.9%
2 Apr 2013
VP AND GC
Sold, plan not stated
13,163
$105.30K
24.8%
28 Nov 2012
VP AND GC
Sold, plan not stated
4,396
$23.09K
9.2%
27 Nov 2012
VP AND GC
Sold, plan not stated
16,206
$101.75K
25.4%
25 decisions on file.